1. INSERM, Unité Mixte de Recherche (UMR) 1170, Villejuif, France;
2. Université Paris-Saclay, UMR 1170, Villejuif, France;
3. Gustave Roussy, UMR 1170, Villejuif, France;
4. Signal Transduction and Molecular Hematology Unit, Ludwig Institute for Cancer Research, Brussels, Belgium;
5. de Duve Institute, Université Catholique de Louvain, Brussels, Belgium; and
6. CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria